Low-dose daily aspirin enough to help heart attack patients: study

March 26, 2012
Low-Dose daily aspirin enough to help heart attack patients: study
Using higher dosage didn't improve outcomes, but might increase bleeding risks, experts say.

(HealthDay) -- Heart attack patients who take either a high or low dose of aspirin daily have the same level of protection against another heart attack or other cardiovascular events such as stroke, according to a new study.

Along with anti-clotting drugs, a daily aspirin is recommended for nearly all of the more than one million Americans who suffer a each year, but the most effective dose hasn't been determined.

Higher doses of aspirin typically come with higher bleeding risks, so determining whether a high dose is needed or not has patient safety implications.

To clarify the issue, researchers analyzed data from more than 11,000 around the world who were prescribed either a low daily dose (150 milligrams or less) or a high daily dose (more than 150 milligrams) of aspirin along with anti-clotting medications.

The findings were to be presented Saturday at the annual meeting of the American College of Cardiology in Chicago.

"We observed no difference between patients taking a high dose versus a low dose of aspirin as it relates to , heart attack, stroke or stent [clot]," lead author Dr. Payal Kohli, a cardiology fellow at Brigham and Women's Hospital, said in a hospital news release.

"Interestingly, we did find a dramatic difference in of physicians in North America compared to those in the rest of the world," Kohli added. "North American physicians prescribed a high dose of aspirin for two-thirds of all their patients, while the exact reverse was true of the rest of the world. International physicians prescribed a low dose of aspirin to more than two-thirds of their patients."

Patients who received high doses of aspirin were more likely to have cardiac risk factors and higher , while those who received low doses were more likely to be white and have no prior history of .

One expert said the study confirms there is "no role for high-dose aspirin" in this type of scenario. Dr. Jenifer Yu, a cardiologist and research fellow at Mount Sinai Medical Center in New York City, said she and her colleagues published similar findings at the American Heart Association annual meeting in 2011.

In that study, "after adjusting for baseline differences in the two groups, we found that the use of high-dose aspirin (greater than 200 milligrams) afforded no additional protection with respect to ischemic events [such as heart attack or stroke] in comparison to low-dose aspirin (less than 200 )," Yu noted. "However, patients on high-dose aspirin experienced more major bleeding," she added.

The newer study from Brigham & Women's also found that the anti-clotting drug prasugrel (brand name Effient) was more effective at preventing major than the anti-clotting drug clopidogrel (brand name Plavix), regardless of whether patients took low- or high-dose aspirin.

Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.

Explore further: Ibuprofen puts high risk cardiac patients at risk

More information: The American Heart Association has more about aspirin and heart disease.

Related Stories

Ibuprofen puts high risk cardiac patients at risk

April 5, 2007

Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious. A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in ...

Aspirin in Heart Attack Prevention: How Much, How Long?

January 15, 2008

A low dose of aspirin appears to be just as effective as a higher dose in preventing a heart attack, stroke or death among patients with stable cardiovascular disease, say researchers at Duke University Medical Center.

Even low-dose aspirin may increase risk of GI bleeding

September 12, 2011

The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical ...

Recommended for you

Amyloid-related heart failure now detectable with imaging test

August 24, 2016

A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy, according to a multicenter study led by researchers at Columbia ...

Biomarkers may help better predict who will have a stroke

August 24, 2016

People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.